IBDEI1II ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,24184,1,4,0)
 ;;=4^L53.8
 ;;^UTILITY(U,$J,358.3,24184,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,24185,0)
 ;;=L53.9^^107^1201^149
 ;;^UTILITY(U,$J,358.3,24185,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24185,1,3,0)
 ;;=3^Erythematous Condition,Unspec
 ;;^UTILITY(U,$J,358.3,24185,1,4,0)
 ;;=4^L53.9
 ;;^UTILITY(U,$J,358.3,24185,2)
 ;;=^5009210
 ;;^UTILITY(U,$J,358.3,24186,0)
 ;;=L54.^^107^1201^148
 ;;^UTILITY(U,$J,358.3,24186,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24186,1,3,0)
 ;;=3^Erythema in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,24186,1,4,0)
 ;;=4^L54.
 ;;^UTILITY(U,$J,358.3,24186,2)
 ;;=^5009211
 ;;^UTILITY(U,$J,358.3,24187,0)
 ;;=L56.0^^107^1201^142
 ;;^UTILITY(U,$J,358.3,24187,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24187,1,3,0)
 ;;=3^Drug Phototoxic Response
 ;;^UTILITY(U,$J,358.3,24187,1,4,0)
 ;;=4^L56.0
 ;;^UTILITY(U,$J,358.3,24187,2)
 ;;=^5009214
 ;;^UTILITY(U,$J,358.3,24188,0)
 ;;=L56.1^^107^1201^141
 ;;^UTILITY(U,$J,358.3,24188,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24188,1,3,0)
 ;;=3^Drug Photoallergic Response
 ;;^UTILITY(U,$J,358.3,24188,1,4,0)
 ;;=4^L56.1
 ;;^UTILITY(U,$J,358.3,24188,2)
 ;;=^5009215
 ;;^UTILITY(U,$J,358.3,24189,0)
 ;;=L56.2^^107^1201^274
 ;;^UTILITY(U,$J,358.3,24189,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24189,1,3,0)
 ;;=3^Photocontact Dermatitis
 ;;^UTILITY(U,$J,358.3,24189,1,4,0)
 ;;=4^L56.2
 ;;^UTILITY(U,$J,358.3,24189,2)
 ;;=^5009216
 ;;^UTILITY(U,$J,358.3,24190,0)
 ;;=L56.3^^107^1201^308
 ;;^UTILITY(U,$J,358.3,24190,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24190,1,3,0)
 ;;=3^Solar Urticaria
 ;;^UTILITY(U,$J,358.3,24190,1,4,0)
 ;;=4^L56.3
 ;;^UTILITY(U,$J,358.3,24190,2)
 ;;=^5009217
 ;;^UTILITY(U,$J,358.3,24191,0)
 ;;=L57.0^^107^1201^13
 ;;^UTILITY(U,$J,358.3,24191,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24191,1,3,0)
 ;;=3^Actinic Keratosis
 ;;^UTILITY(U,$J,358.3,24191,1,4,0)
 ;;=4^L57.0
 ;;^UTILITY(U,$J,358.3,24191,2)
 ;;=^66900
 ;;^UTILITY(U,$J,358.3,24192,0)
 ;;=L60.0^^107^1201^164
 ;;^UTILITY(U,$J,358.3,24192,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24192,1,3,0)
 ;;=3^Ingrowing Nail
 ;;^UTILITY(U,$J,358.3,24192,1,4,0)
 ;;=4^L60.0
 ;;^UTILITY(U,$J,358.3,24192,2)
 ;;=^5009234
 ;;^UTILITY(U,$J,358.3,24193,0)
 ;;=L60.1^^107^1201^272
 ;;^UTILITY(U,$J,358.3,24193,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24193,1,3,0)
 ;;=3^Onycholysis
 ;;^UTILITY(U,$J,358.3,24193,1,4,0)
 ;;=4^L60.1
 ;;^UTILITY(U,$J,358.3,24193,2)
 ;;=^186837
 ;;^UTILITY(U,$J,358.3,24194,0)
 ;;=L60.2^^107^1201^271
 ;;^UTILITY(U,$J,358.3,24194,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24194,1,3,0)
 ;;=3^Onychogryphosis
 ;;^UTILITY(U,$J,358.3,24194,1,4,0)
 ;;=4^L60.2
 ;;^UTILITY(U,$J,358.3,24194,2)
 ;;=^5009235
 ;;^UTILITY(U,$J,358.3,24195,0)
 ;;=L60.3^^107^1201^176
 ;;^UTILITY(U,$J,358.3,24195,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24195,1,3,0)
 ;;=3^Nail Dystrophy
 ;;^UTILITY(U,$J,358.3,24195,1,4,0)
 ;;=4^L60.3
 ;;^UTILITY(U,$J,358.3,24195,2)
 ;;=^5009236
 ;;^UTILITY(U,$J,358.3,24196,0)
 ;;=L60.4^^107^1201^89
 ;;^UTILITY(U,$J,358.3,24196,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,24196,1,3,0)
 ;;=3^Beau's Lines
 ;;^UTILITY(U,$J,358.3,24196,1,4,0)
 ;;=4^L60.4
 ;;^UTILITY(U,$J,358.3,24196,2)
 ;;=^5009237
 ;;^UTILITY(U,$J,358.3,24197,0)
 ;;=L60.5^^107^1201^330
 ;;^UTILITY(U,$J,358.3,24197,1,0)
 ;;=^358.31IA^4^2
